Home › Duchenne Muscular Dystrophy › District of Columbia › Washington
Duchenne Muscular Dystrophy clinical trials in Washington, DC
5 studies for Duchenne Muscular Dystrophy are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
RecruitingObservational study
- Children's National Health System, Washington D.C.
Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
RecruitingObservational study
- Children's National, Washington D.C.
A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
RecruitingObservational study
- Children's National Hospital, Washington D.C.
Duchenne Electronic Health Record Study
RecruitingObservational study
- Children's National Medical Center, Washington D.C.
The Duchenne Registry
RecruitingObservational study
- The Duchenne Registry / PPMD, Washington D.C.
Duchenne Muscular Dystrophy trials in other cities
- Little Rock, AR7 studies
- Chicago, IL5 studies
- Durham, NC5 studies
- Sacramento, CA5 studies
- Gainesville, FL5 studies
- Boston, MA5 studies
- Nashville, TN4 studies
- Columbus, OH4 studies
- Seattle, WA3 studies
- Mountain View, CA3 studies
- Los Angeles, CA3 studies
- St. Louis, MO3 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.